Myhep LVR

**MyHep LVR** is a combination antiviral medication that contains the following active ingredients: **Ledipasvir (90 mg)** and **Sofosbuvir (400 mg)**. This combination is primarily used to treat chronic hepatitis C virus (HCV) infection, particularly in adults. ### PRODUCT DESCRIPTION **MyHep LVR** is indicated for the treatment of adult patients with chronic hepatitis C, and it is effective against several genotypes of the virus. Ledipasvir and Sofosbuvir work synergistically to inhibit the replication of the hepatitis C virus and promote viral clearance. ### COMPOSITION Each tablet of MyHep LVR contains: – **Ledipasvir** – 90 mg – **Sofosbuvir** – 400 mg – **Excipients** – (inactive ingredients that aid in the formulation of the tablet) ### MECHANISM OF ACTION – **Ledipasvir**: This is an NS5A inhibitor that interferes with the hepatitis C virus’s lifecycle, specifically blocking the replication and assembly process of the virus. – **Sofosbuvir**: This is an NS5B polymerase inhibitor that prevents viral RNA replication by inhibiting the action of the polymerase enzyme necessary for forming new viral RNA. The combination of these two drugs effectively decreases the viral load and increases the chances of achieving a sustained virologic response (SVR). ### DOSAGE – **Recommended Dose**: One tablet (containing 90 mg of Ledipasvir and 400 mg of Sofosbuvir) taken once daily. – It can be taken with or without food, and it is essential to take it at the same time each day to maximize its effectiveness. ### USES MyHep LVR is indicated for: – The treatment of chronic hepatitis C in adults, including those with or without cirrhosis. It is effective across several genotypes of the hepatitis C virus. ### SIDE EFFECTS Common side effects associated with MyHep LVR may include: – Fatigue – Headache – Nausea – Diarrhea – Insomnia – Rash Serious side effects are rare but can include liver function abnormalities, severe allergic reactions, and other complications. It is important for patients to be vigilant for any unusual symptoms and to contact their healthcare provider if they occur. ### IMPORTANT NOTE – MyHep LVR should always be used in accordance with a healthcare provider’s recommendation and should not be prescribed as monotherapy. It is usually part of a broader treatment regimen. – Regular monitoring through follow-up appointments and laboratory tests is essential to track the response to treatment and ensure liver health. ### RECOMMENDATION – Patients should follow the prescribed dosage closely and should not skip doses. If a dose is missed, it should be taken as soon as the patient remembers, unless it is close to the time for the next dose. – Discuss all medications being taken, including over-the-counter products, with a healthcare provider to minimize potential drug interactions. – For pregnant or breastfeeding individuals, consultation with a healthcare provider is essential before starting therapy. ### Disclaimer Before starting treatment with **MyHep LVR**, consult a healthcare professional for personalized advice, to discuss potential drug interactions, and to receive a tailored treatment plan based on individual health needs and circumstances.